bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026)
bioAffinity Technologies (BIAF) reported Non-Current Assets of $3.6 million for Q1 2026, down 2.16% year-over-year from $3.7 million in Q1 2025, and up 6.13% quarter-over-quarter from $3.4 million in Q4 2025.
bioAffinity Technologies (BIAF) Non-Current Assets (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Non-Current Assets data on file, last reported at $3.6 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $3.6 million, down 2.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (down 15.93% YoY), and the FY2025 annual result was $3.4 million, down 11.08% from the prior year.
- Non-Current Assets improved to $3.6 million in Q1 2026 per BIAF's latest filing, from $3.4 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $4.2 million in Q4 2023 and troughed at $7781.0 in Q3 2022.
- A 5-year average of $2.8 million and a median of $3.6 million in 2026 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 53611.03% in 2023, then decreased 26.73% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $220438.0 in 2022, then jumped by 1827.44% to $4.2 million in 2023, then decreased by 10.13% to $3.8 million in 2024, then retreated by 11.08% to $3.4 million in 2025, then advanced by 6.13% to $3.6 million in 2026.
- Business Quant data shows BIAF's Non-Current Assets at $3.6 million in Q1 2026, $3.4 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 20.47 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 90.97 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 69.61 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 1.93 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 8.30 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 962.59 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 23.46 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.82 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.34 Bn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.68 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 30, 2023 | 4.18 Mn |
| Jun 30, 2023 | 214,296.00 |
| Mar 31, 2023 | 231,987.00 |
| Dec 31, 2022 | 220,438.00 |
| Sep 30, 2022 | 7,781.00 |
| Dec 31, 2021 | 15,075.00 |